10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

Once a decade discount

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Synageva BioPharma Corp (GEVA) SVP, CFO Carsten Boess sells 9,927 Shares

January 22, 2013 | About:
insider

insider

57 followers
SVP, CFO of Synageva BioPharma Corp (GEVA) Carsten Boess sells 9,927 shares of GEVA on 01/16/2013 at an average price of $49.12 a share.

Synageva Biopharma Corp has a market cap of $1.23 billion; its shares were traded at around $50.74 with and P/S ratio of 83.8.

This is the annual revenues and earnings per share of GEVA over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of GEVA.


CEO Recent Trades:



  • President & CEO Sanj K Patel sold 60,000 shares of GEVA stock on 12/17/2012 at the average price of 46.21. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 9.8% since.
  • President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/05/2012 at the average price of 48.92. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 3.72% since.
  • President & CEO Sanj K Patel sold 35,000 shares of GEVA stock on 12/03/2012 at the average price of 49.34. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.84% since.
  • President & CEO Sanj K Patel sold 70,000 shares of GEVA stock on 09/04/2012 at the average price of 49.47. Sanj K Patel owns at least 1,317 shares after this. The price of the stock has increased by 2.57% since.

CFO Recent Trades:



  • SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 01/16/2013 at the average price of 49.12. The price of the stock has increased by 3.3% since.
  • SVP, CFO Carsten Boess sold 9,927 shares of GEVA stock on 10/16/2012 at the average price of 50.13. The price of the stock has increased by 1.22% since.

This is the insider trade history vs. stock price of GEVA. For the complete insider trading history of GEVA, click here.




Directors and Officers Recent Trades:



  • Director Thomas J Tisch bought 21,039 shares of GEVA stock on 01/09/2013 at the average price of 47.53. Thomas J Tisch owns at least 751,995 shares after this. The price of the stock has increased by 6.75% since.
  • Director, 10% Owner Felix Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Felix Baker owns at least 1,736,565 shares after this. The price of the stock has increased by 6.75% since.
  • Director, 10% Owner Julian Baker bought 859,720 shares of GEVA stock on 01/04/2013 at the average price of 47.53. Julian Baker owns at least 1,737,085 shares after this. The price of the stock has increased by 6.75% since.
  • SVP, Chief Medical Officer Anthony Quinn sold 5,553 shares of GEVA stock on 01/17/2013 at the average price of 50.07. Anthony Quinn owns at least 15,035 shares after this. The price of the stock has increased by 1.34% since.
  • SVP, Product Development Mark Alan Goldberg sold 4,417 shares of GEVA stock on 01/02/2013 at the average price of 47.52. The price of the stock has increased by 6.78% since.


For the complete insider trading history of GEVA, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK